Evidence map›Paper›PMID 24465906›Full record

ArticlePloS one2014

Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.

Jirko Kühnisch, Jong Seto, Claudia Lange, Susanne Schrof, Sabine Stumpp, Karolina Kobus, Julia Grohmann, Nadine Kossler, Peter Varga, Monika Osswald and 13 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Identifying Bone Matrix Impairments in a Mouse Model of Neurofibromatosis Type 1 (NF1) by Clinically Translatable Techniques.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bones.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2015
    Review
  12. Biological regulation of bone quality.Current osteoporosis reports · 2014
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 11 institutions in 3 countries.

Jirko KühnischInstitute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, Berlin, Germany ; FG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Jong SetoDepartment of Biomaterials, Max Planck Institute for Colloids and Interfaces, Potsdam, Germany ; Department of Chemistry, Universität Konstanz, Konstanz, Germany.
Claudia LangeDepartment of Biomaterials, Max Planck Institute for Colloids and Interfaces, Potsdam, Germany ; Institut für Physiologische Chemie, MTZ, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Susanne SchrofJulius Wolff Institute & Brandenburg School of Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Sabine StumppInstitute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Karolina KobusFG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Julia GrohmannFG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Nadine KosslerFG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Peter VargaJulius Wolff Institute & Brandenburg School of Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Monika OsswaldFG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Denise EmmerichInstitute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, Berlin, Germany ; FG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Sigrid TinschertDivision für Humangenetik, Medizinische Universität Innsbruck, Innsbruck, Austria ; Institut für Klinische Genetik, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Falk ThielemannKlinik für Orthopädie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Georg DudaJulius Wolff Institute & Brandenburg School of Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany ; Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany.
Wenke SeifertInstitute for Vegetative Anatomy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Thaqif El KhassawnaLaboratory of Experimental Trauma Surgery Giessen, Justus-Liebig University Giessen, Giessen, Germany.
David A StevensonUniversity of Utah, Department of Pediatrics, Division of Medical Genetics, Salt Lake City, Utah, United States of America.
Florent ElefteriouDepartment of Medicine, Pharmacology and Cancer Biology, Center for Bone Biology, Vanderbilt University - Medical Center, Nashville, Tennessee, United States of America.
Uwe KornakInstitute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, Berlin, Germany ; FG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Kay RaumJulius Wolff Institute & Brandenburg School of Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Peter FratzlDepartment of Biomaterials, Max Planck Institute for Colloids and Interfaces, Potsdam, Germany ; Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany.
Stefan MundlosInstitute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, Berlin, Germany ; FG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany ; Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany.
Mateusz KolanczykInstitute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, Berlin, Germany ; FG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Max Planck Institute for Molecular Genetics · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DECharité - Universitätsmedizin Berlin · DEInnsbruck Medical University · ATMax Planck Institute of Colloids and Interfaces · DETU Dresden · DEUniversity Hospital Carl Gustav Carus · DEUniversity of Giessen · DEUniversity of Konstanz · DEUniversity of Utah · USVanderbilt University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone fragility due to osteopenia, osteoporosis or debilitating focal skeletal dysplasias is a frequent observation in the Mendelian disease Neurofibromatosis type 1 (NF1). To determine the mechanisms underlying bone fragility in NF1 we analyzed two conditional mouse models, Nf1Prx1 (limb knock-out) and Nf1Col1 (osteoblast specific knock-out), as well as cortical bone samples from individuals with NF1. We examined mouse bone tissue with micro-computed tomography, qualitative and quantitative histology, mechanical tensile analysis, small-angle X-ray scattering (SAXS), energy dispersive X-ray spectroscopy (EDX), and scanning acoustic microscopy (SAM). In cortical bone of Nf1Prx1 mice we detected ectopic blood vessels that were associated with diaphyseal mineralization defects. Defective mineral binding in the proximity of blood vessels was most likely due to impaired bone collagen formation, as these areas were completely devoid of acidic matrix proteins and contained thin collagen fibers. Additionally, we found significantly reduced mechanical strength of the bone material, which was partially caused by increased osteocyte volume. Consistent with these observations, bone samples from individuals with NF1 and tibial dysplasia showed increased osteocyte lacuna volume. Reduced mechanical properties were associated with diminished matrix stiffness, as determined by SAM. In line with these observations, bone tissue from individuals with NF1 and tibial dysplasia showed heterogeneous mineralization and reduced collagen fiber thickness and packaging. Collectively, the data indicate that bone fragility in NF1 tibial dysplasia is partly due to an increased osteocyte-related micro-porosity, hypomineralization, a generalized defect of organic matrix formation, exacerbated in the regions of tensional and bending force integration, and finally persistence of ectopic blood vessels associated with localized macro-porotic bone lesions.

Indexed as

Calcification, PhysiologicAnimalsBiomechanical PhenomenaBlood VesselsBone and BonesBone DensityBone MatrixCollagenDiaphysesHomeodomain ProteinsMiceMice, KnockoutNeurofibromatosis 1Neurofibromin 1OsteocytesPorosityCollagenHomeodomain ProteinsNeurofibromin 1Prrx1 protein, mouse

Identifiers

PMID24465906
PMCPMC3897656
OpenAlexW2058086606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.